|
领航医药及生物科技有限公司, 00399.HK - 综合损益表 |
2023-03 |
2022-03 |
2021-03 |
2020-03 |
2019-03 |
2018-03 |
2017-03 |
2016-03 |
2015-03 |
2014-03 |
2013-06 |
2012-06 |
2011-06 |
2010-06 |
2009-06 |
2008-06 |
2007-06 |
2006-06 |
2005-06 |
营业额 |
8,075 |
11,145 |
15,189 |
14,580 |
18,589 |
15,811 |
9,187 |
19,908 |
33,976 |
29,744 |
7,747 |
25,475 |
90,193 |
483,947 |
374,442 |
317,041 |
83,111 |
32,028 |
29,061 |
经营溢利 |
-254,671 |
36,431 |
-212,155 |
-228,774 |
-274,237 |
-239,623 |
-188,353 |
-248,892 |
-457,209 |
-553,351 |
-44,919 |
-35,406 |
8,695 |
13,492 |
612,448 |
-8,599 |
-3,674 |
-52,953 |
-40,997 |
非经营/ 特殊项目 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
161 |
-184 |
133,883 |
-59,947 |
-60,457 |
0 |
0 |
联营公司 |
0 |
0 |
0 |
6,312 |
13,326 |
8,632 |
10,011 |
7,945 |
295 |
-3,987 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
除税前经营溢利 |
-254,671 |
36,431 |
-212,155 |
-222,462 |
-260,911 |
-230,991 |
-178,342 |
-240,947 |
-456,914 |
-557,338 |
-47,193 |
-131,757 |
8,856 |
13,308 |
746,331 |
-68,546 |
-64,131 |
-52,953 |
-40,997 |
税项 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-10 |
-2,060 |
3,250 |
2,132 |
1,090 |
33 |
10 |
0 |
0 |
少数股东权益 |
-8,973 |
-9,372 |
-7,216 |
-11,345 |
-639 |
57 |
-8,554 |
-4,082 |
-5,230 |
-6,851 |
-16,818 |
-5,815 |
359 |
-86 |
36 |
42 |
9 |
0 |
0 |
股东应占溢利 |
-245,698 |
45,803 |
-204,939 |
-211,117 |
-260,272 |
-231,048 |
-169,788 |
-236,865 |
-451,684 |
-550,347 |
-72,839 |
-123,882 |
5,247 |
11,262 |
745,205 |
-68,621 |
-64,150 |
-52,953 |
-40,997 |
货币 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
单位 |
千 |
千 |
千 |
千 |
千 |
千 |
千 |
千 |
主要项目 |
折旧 |
1,881 |
2,130 |
2,309 |
1,244 |
67 |
617 |
1,171 |
1,164 |
1,286 |
2,870 |
10,484 |
6,697 |
764 |
456 |
1,093 |
2,837 |
2,957 |
2,699 |
2,557 |
利息 |
233,969 |
189,951 |
191,032 |
147,039 |
131,693 |
110,725 |
108,034 |
79,562 |
52,937 |
5,105 |
938 |
150 |
0 |
184 |
633 |
59,947 |
60,457 |
49,936 |
35,848 |
利息拨作发展资本 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
处置/重估固定资产 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
税率(%) |
|
|
|
|
|
|
|
|
|
|
0.02 |
|
36.7 |
16.02 |
0.15 |
|
|
|
|
营业额增长(%) |
-27.55 |
-26.62 |
4.18 |
-21.57 |
17.57 |
72.1 |
-53.85 |
-41.41 |
14.23 |
0.0 |
-69.59 |
-71.76 |
-81.36 |
29.24 |
18.11 |
281.47 |
159.49 |
10.21 |
-0.11 |
股东应占溢利增长(%) |
0.0 |
0.0 |
2.93 |
18.89 |
-12.65 |
-36.08 |
28.32 |
47.56 |
-17.93 |
0.0 |
-41.2 |
|
-53.41 |
-98.49 |
|
|
|
|
|
核数师意见 |
2 |
1 |
2 |
2 |
2 |
2 |
2 |
1 |
1 |
1 |
1 |
1 |
1 |
0 |
1 |
1 |
2 |
2 |
2 |
说明:1代表无保留意见;2代表保留意见;3代表修改意见
|
|